-
ICD-10-CM Codes
›
-
C00-D49
›
-
C81-C96
›
-
C96-
›
-
2023 ICD-10-CM Diagnosis Code C96
2023 ICD-10-CM Diagnosis Code C96
Other and unspecified malignant neoplasms of lymphoid, hematopoietic and related tissue
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
- C96 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
- Short description: Oth & unsp malig neoplm of lymphoid, hematpoetc and rel tiss
- The 2023 edition of ICD-10-CM C96 became effective on October 1, 2022.
- This is the American ICD-10-CM version of C96 - other international versions of ICD-10 C96 may differ.
Type 1 ExcludesType 1 Excludes Help
A type 1 excludes note is a pure excludes. It means "not coded here". A type 1 excludes note indicates that the code excluded should never be used at the same time as C96. A type 1 excludes note is for used for when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
The following code(s) above
C96 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
- Applicable To annotations, or
- Code Also annotations, or
- Code First annotations, or
- Excludes1 annotations, or
- Excludes2 annotations, or
- Includes annotations, or
- Note annotations, or
- Use Additional annotations
that may be applicable to
C96:
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
Code annotations containing back-references to C96:
-
Type 1 Excludes: C77
ICD-10-CM Diagnosis Code C77
Secondary and unspecified malignant neoplasm of lymph nodes
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Type 1 Excludes- malignant neoplasm of lymph nodes, specified as primary (C81-C86, C88, C96.-)
- mesentary metastasis of carcinoid tumor (C7B.04)
- secondary carcinoid tumors of distant lymph nodes (C7B.01)
-
Applicable To: Z80.7, Z85.79
ICD-10-CM Diagnosis Code Z80.7
Family history of other malignant neoplasms of lymphoid, hematopoietic and related tissues
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
ICD-10-CM Diagnosis Code Z85.79
Personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
Type 1 Excludes- multiple myeloma in remission (C90.01)
- plasma cell leukemia in remission (C90.11)
- plasmacytoma in remission (C90.21)
ICD-10-CM Codes Adjacent To C96
C95.1 Chronic leukemia of unspecified cell type
C95.10 …… not having achieved remission
C95.9 Leukemia, unspecified
C95.90 …… not having achieved remission
C96
Other and unspecified malignant neoplasms of lymphoid, hematopoietic and related tissue
C96.0 Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis
C96.2 Malignant mast cell neoplasm
C96.21 Aggressive systemic mastocytosis
C96.29 Other malignant mast cell neoplasm
C96.4 Sarcoma of dendritic cells (accessory cells)
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
C96.6 Unifocal Langerhans-cell histiocytosis
C96.A Histiocytic sarcoma
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.